Navigation Links
CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
Date:5/1/2008

Emerging spinal company continues to focus on unmet needs of the lumbar

disc

MINNEAPOLIS, May 1 /PRNewswire/ -- CoreSpine Technologies, LLC, an emerging spinal device company announced today the expansion of its platform technology for spinal implant procedures to include an application for minimally invasive fusion.

The development of CoreSpine's Technologies' initial prototype concentrated on generating a complete and selective nucleus removal device. The technology was recently expanded to incorporate a cartilage removal device for endplate preparation. The importance of the company's proprietary technology is elevated as spinal implants and therapies begin to require more effective nucleus removal and endplate preparation through limited access.

There is a strong momentum within the spine industry to move in the direction of products that support tissue sparing, motion preserving and minimally invasive techniques. The goal of CoreSpine's proprietary technology is to universally meet the specific preparation requirements of both current and emerging implant technologies.

Initial data to support the technology's enhanced ability over existing options will be presented at the Spine Arthroplasty Society's 8th annual meeting in Miami. The presentation by John Sherman, M.D., Medical Director for CoreSpine will occur on Friday, May 9th at 3:09 p.m. The presentation consists of initial data collected using CoreSpine's prototype for nucleus removal. Additional information will be available in CoreSpine's booth, #327, during the SAS meeting.

About CoreSpine Technologies, LLC

CoreSpine Technologies, LLC is headquartered in Minneapolis, MN. The company is focused on developing a platform technology to produce advanced surgical devices for the complete or selective removal of material from the lumbar disc space. The devices are intended for use in the rapidly emerging and changing fields of spinal therapies. The first products will set the standard for preparing the spinal disc for artificial nucleus replacement and minimally invasive fusion devices, becoming the preferred method for effective and safe preparation of the lumbar spinal disc space. For additional information, please visit the company's website at http://www.corespinetech.com or visit booth #327 during the Spine Arthroplasty Society's Annual Meeting.


'/>"/>
SOURCE CoreSpine Technologies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
2. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
5. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
6. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
7. Senesco Technologies Initiates Preclinical Studies for Cancer Target
8. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of ... 27, 2017 to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... CaryRx, a next-generation full-service pharmacy, has announced the ... in the Washington D.C. metropolitan area. ... delivery of medications through the convenience of its patient-friendly mobile ... within one hour to any location in D.C. ... invaluable service to Washington D.C. ," says ...
Breaking Medicine Technology:
(Date:8/24/2017)... ... August 24, 2017 , ... Prime candidates ... recovered, or have a condition that needs further monitoring such as surgery, stroke, ... monitoring until stable, such as diabetes, high blood pressure, heart/lung disease, arthritis and ...
(Date:8/23/2017)... Jose, California (PRWEB) , ... August 23, 2017 , ... ... San Jose, California, office at 1530 The Alameda, Suite 115. The office is located ... has changed, the contact information remains the same. Clients can still call the office ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... to prove the safety and efficacy of HBOT in treating and helping to ... US, points to research showing the similarities of the wounds to the brain ...
(Date:8/23/2017)... ... August 23, 2017 , ... Cirrus Medical Staffing, one of ... http://www.cirrusmedicalstaffing.com . The new site pairs a robust job search with a ... are traveling on short-term assignments to healthcare facilities around the country. , “We ...
(Date:8/23/2017)... ... August 23, 2017 , ... Virsys12, a Salesforce Gold ... announcing the hiring of Kevin Keelan as a Senior Account Executive, based in ... Keelan will be working with Virsys12 senior leadership to extend and develop the ...
Breaking Medicine News(10 mins):